UK Edition. Click here for US version.
GALEBON 0.4MG PROLONGED-RELEASE CAPSULES
Active substance(s): TAMSULOSIN HYDROCHLORIDE
Galebon 0.4 mg prolonged-release capsules, hard
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
• Keep this leaflet. You may need to read it again.
• If you have any further questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
• If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.
What is in this leaflet
1. What Galebon 0.4 mg prolonged-release capsules, hard (referred as Galebon throughout the remainder of this leaflet) is and what it is used for
2. What you need to know before you take Galebon
3. How to take Galebon
4. Possible side effects
5. How to store Galebon
6. Contents of the pack and other information
1. WHAT GALEBON IS AND WHAT IT IS USED FOR
The active ingredient in Galebon is tamsulosin hydrochloride. This is a selective alpha1A/1D-adrenoceptor antagonist. It reduces tension of the smooth muscles in the prostate
and the urethra, enabling urine to pass more readily through the urethra and facilitating urination. In addition, it diminishes sensations of urge.
Galebon is used in men for the treatment of the complaints of the lower urinary tract associated with an enlarged prostate (benign prostatic hyperplasia). These complaints
may include difficulty urinating (poor stream), dribbling, urgency and having to urinate frequently at night as well as during the day.
2. What you need to know before you take Galebon
Do not take Galebon:
• if you are allergic to tamsulosin hydrochloride or any of the other ingredients of this medicine (listed in section 6). Hypersensitivity may present as sudden local swelling of
soft tissues of the body (e.g. the throat or tongue), difficult breathing and/or itching and rash (angioedema).
• if you have severe liver insufficiency.
• if you suffer from fainting due to reduced blood pressure when changing posture (going to sit or stand up).
Warnings and precautions
Talk to your doctor or pharmacist before taking Galebon.
• Periodic medical examinations are necessary to monitor the development of the condition you are being treated for.
• Rarely, fainting can occur during the use of tamsulosin, as with other medicinal products of this type. At the first signs of dizziness or weakness you should sit or lie down
until they have disappeared.
• If you suffer from severe kidney problems, tell your doctor.
• If you are undergoing or have been scheduled for eye surgery because of cloudiness of the lens (cataract) or increased internal pressure of the eye (glaucoma), please inform
your eye specialist that you are using or have previously used Galebon. This is because Galebon may cause complications during the surgery. The specialist can then take
appropriate precautions with respect to medication and surgical techniques to be used. Ask your doctor whether or not you should postpone or temporarily stop taking this
medicine when undergoing eye surgery because of a cloudy lens (cataract) or increased internal pressure of the eye (glaucoma).
Children and adolescents
Do not give this medicine to children or adolescent under 18 years because there is no relevant indication for use of Galebon in this age group and its efficacy has not been
established in this population.
Other medicines and Galebon
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Certain medicines (e.g., medicines preventing blood clotting called anticoagulants such as warfarin, anti-inflammatory drugs such as diclofenac) can influence the effects of
tamsulosin. Therefore, you can only take medicines concomitantly with Galebon if your doctor allows it.
Pregnancy, breast-feeding and fertility
Galebon is not indicated for use in women.
In men, abnormal ejaculation has been reported (ejaculation disorder).
This means that the semen does not leave the body via the urethra, but instead goes into the bladder (retrograde ejaculation) or the ejaculation volume is reduced or absent
(ejaculation failure). This phenomenon is harmless.
Driving and using machines
Galebon can adversely affect the ability to drive or operate machines. It should be taken into account that in some patients dizziness may occur.
3. HOW TO TAKE GALEBON
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
If it is not prescribed otherwise by your doctor the recommended dose is one capsule daily, to be taken after breakfast or the first meal of the day.
Do not crunch or chew the capsule, swallow it whole.
If you take more Galebon than you should
Taking more Galebon may lead to unexpected drop of blood pressure and rapid heart beat, followed by dizziness. Contact your doctor immediately or visit the emergency
department of the nearest hospital as the consequences of accidental or deliberate overdose may require medical intervention.
If you forget to take Galebon
Take the forgotten capsule on the same day. However, on the next day do not take a double dose to make up for a forgotten dose; just resume treatment at one capsule a day.
If you stop taking Galebon
You should not stop taking it without consulting your doctor before.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
4. POSSIBLE SIDE EFFECTS
Like all medicines, this medicine can cause side effects, although not everybody gets them. Do not be alarmed by this list of possible side effects, you may not have any of them.
Most patients do not notice any side effects. However if you do and they bother you, talk to your doctor.
If you begin to feel light-headed or dizzy, sit or lie down until you feel better.
Common (may affect up to 1 in 10 people):
• dizziness, especially when you are getting up from a chair or bed
• ejaculation disorders
Uncommon (may affect up to 1 in 100 people):
• rapid heartbeat
• dropping of blood pressure especially when standing up
• obstructed or runny nose
• nettle rash
Rare (may affect up to 1 in 1,000 people):
• swelling of the lower layers of the skin, often around the mouth or of the mucosa of the mouth or throat which can appear very quickly
Very rare (may affect up to 1 in 10,000 people):
• priapism (painful, persistent, involuntary erection of the penis), in which case immediate medical aid is needed
• a severe inflammatory eruption of the skin and mucous membranes, which is an allergic reaction to drugs or other substances called Stevens-Johnson syndrome
Not known (frequency cannot be estimated from the available data):
• nose bleeding
• vision blurred, visual impairment
• dry mouth
• serious skin rashes (erythema multiforme, dermatitis exfoliative)
• retrograde ejaculation (ejaculation into the bladder)
• failure of ejaculation
If you are undergoing eye surgery because of cloudiness of the lens (cataract) or increased internal pressure of the eye (glaucoma), and are already taking or have previously taken
tamsulosin hydrochloride, the pupil may dilate poorly and the iris (the coloured circular part of the eye) may become floppy during the procedure (see also section 2 “Warnings and
In addition to the adverse events listed above,
• very rapid uncoordinated contractions of the heart
• irregular rhythm of the heartbeat
• abnormally rapid heart rate
• difficulty in breathing
have been reported in association with Galebon use. Because these spontaneously reported events are from the worldwide post-marketing experience, the frequency of events and
the role of Galebon in their causation cannot be reliably determined.
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the
Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more
information on the safety of this medicine.
5. HOW TO STORE GALEBON
Keep this medicine out of the sight and reach of children.
Store in the original package in order to protect from light.
Do not use this medicine after the expiry date which is stated on the carton after ’Exp.:’. The expiry date refers to the last day of that month.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect
6. Contents of the pack and other information
What Galebon contains
• The active substance is tamsulosin hydrochloride. Each capsule contains 0.4 milligram of tamsulosin hydrochloride.
• The other ingredients are:
capsule filling: microcrystalline cellulose (E460), methacrylic acid-ethyl acrylate copolymer 1:1 (including polysorbate, sodium lauryl sulfate), talc, triethyl citrate, calcium
capsule shell: yellow iron oxide (E172), black iron oxide (E172), red iron oxide (E172), titanium dioxide (E171), gelatine
What Galebon looks like and contents of the pack
The size No. 2 capsules are opaque with buff-coloured and brown parts. Each prolonged-release capsule, hard is filled with 330 mg white to off-white film-coated pellets.
30, 90 or 100 capsules are packed into PVC/PVDC/Al blisters and carton.
Not all pack sizes may be marketed.
Marketing Authorisation Holder and Manufacturer
Marketing Authorisation Holder:
Consilient Health Ltd., 5th floor, Beaux Lane House, Mercer Street Lower, Dublin 2, Ireland
Gedeon Richter Plc., 1103 Budapest, Gyömrői út 19-21, Hungary
This leaflet was last revised in 10/2017
Source: Medicines and Healthcare Products Regulatory Agency
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.